Form 8-K - Current report:
SEC Accession No. 0001493152-25-010875
Filing Date
2025-03-19
Accepted
2025-03-19 09:00:39
Documents
17
Period of Report
2025-03-17
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 79265
2 ex3-3.htm EX-3.3 55786
3 ex10-1.htm EX-10.1 15440
4 ex10-2.htm EX-10.2 280737
5 ex3-3_001.jpg GRAPHIC 3474
  Complete submission text file 0001493152-25-010875.txt   682297

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mgrx-20250317.xsd EX-101.SCH 3033
7 XBRL LABEL FILE mgrx-20250317_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE mgrx-20250317_pre.xml EX-101.PRE 24177
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3951
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 25750965
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)